Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014664
Status:
UNKNOWN
Last Update Posted:
2013-12-18
First Post:
2001-04-10
Brief Title:
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkins Lymphoma
Sponsor:
PDL BioPharma Inc
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000068585
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PDL BioPharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None